Phase 1 Panic Disorder Clinical Trials
2 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–2 of 2 trials
Not Yet Recruiting
Phase 1
A Phase 1, Randomized, Double-Blind, Placebo-Controlled Single Ascending Dose Study to Assess the Pharmacokinetics, Safety and Tolerability of CBD Inhalation Aerosol in Healthy Adult Volunteers
Panic Disorder
InhaleRx Ltd.24 enrolled1 locationACTRN12625001127493
Completed
Phase 1
A study of RLS103 (CBD-Technosphere® Inhalation Powder) in Healthy Adult Volunteers
Social Anxiety DisorderPanic Disorder
Receptor Life Sciences Australia Pty Ltd30 enrolled1 locationACTRN12621001365853